- Home
- RVPHW vs CORZW Comparison
RVPHW vs CORZW Comparison
Compare RVPHW & CORZW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- CORZW
- Stock Information
- Founded
- RVPHW 2018
- CORZW 2017
- Country
- RVPHW United States
- CORZW United States
- Employees
- RVPHW 14
- CORZW 325
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- CORZW
- Sector
- RVPHW Health Care
- CORZW
- Exchange
- RVPHW Nasdaq
- CORZW Nasdaq
- Market Cap
- RVPHW N/A
- CORZW N/A
- IPO Year
- RVPHW N/A
- CORZW N/A
- Fundamental
- Price
- RVPHW $0.04
- CORZW $16.50
- Analyst Decision
- RVPHW
- CORZW
- Analyst Count
- RVPHW 0
- CORZW 0
- Target Price
- RVPHW N/A
- CORZW N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- CORZW 493.0K
- Earning Date
- RVPHW 03-14-2025
- CORZW 03-13-2025
- Dividend Yield
- RVPHW N/A
- CORZW N/A
- EPS Growth
- RVPHW N/A
- CORZW N/A
- EPS
- RVPHW N/A
- CORZW N/A
- Revenue
- RVPHW N/A
- CORZW $557,676,000.00
- Revenue This Year
- RVPHW N/A
- CORZW N/A
- Revenue Next Year
- RVPHW N/A
- CORZW N/A
- P/E Ratio
- RVPHW N/A
- CORZW N/A
- Revenue Growth
- RVPHW N/A
- CORZW 15.77
- 52 Week Low
- RVPHW $0.13
- CORZW $6.71
- 52 Week High
- RVPHW $0.15
- CORZW $7.00
- Technical
- Relative Strength Index (RSI)
- RVPHW 43.78
- CORZW 76.35
- Support Level
- RVPHW $0.03
- CORZW $13.52
- Resistance Level
- RVPHW $0.05
- CORZW $14.46
- Average True Range (ATR)
- RVPHW 0.01
- CORZW 1.21
- MACD
- RVPHW -0.00
- CORZW 0.27
- Stochastic Oscillator
- RVPHW 23.52
- CORZW 94.39
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CORZW Core Scientific Inc.
Core Scientific Inc is engaged in designing, building and operating digital infrastructure for high-performance computing. The business operates in three operating segments; Digital Asset Self-Mining, consisting of performing digital asset mining for the own account, Digital Asset Hosted Mining, consisting of providing hosting services to third parties for digital asset mining, and HPC Hosting, consisting of providing hosting services to third parties for graphics processing unit (GPU) based HPC hosting operations. The majority of revenue is derived from the Digital Asset Self-Mining Segment.